Quotient invests in radiolabelled services
Quotient Bioresearch has agreed to acquire Amersham Radiolabelling Services and construct a new facility, expanding its radiochemical synthesis, testing and clinical studies offering.
Quotient Bioresearch has agreed to acquire Amersham Radiolabelling Services and construct a new facility, expanding its radiochemical synthesis, testing and clinical studies offering.
Chinese CROs Sundia MediTech, Huiyuan Biotechnology and Frontage Laboratories are the first companies grated express customs clearance privileges under new government pro outsourcing rules.
US CRO PPD has abandoned plans to move into a 40,000 sq ft office building in North Carolina’s Kannapolis biotech complex due to slower than expected development.
Researchers have used nanoparticles to stabilise membrane proteins, allowing for detailed analysis of their structure and molecular functions that could help drug discovery.
US Marshals have seized products from Caraco’s facilities in Michigan because of concerns over cGMP compliance, which has led to Sun Pharma withdrawing its financial guidance.